Literature DB >> 18272394

Expression and characterization of human glycosylated interleukin-1 receptor antagonist in Pichia pastoris.

Brian S Hamilton1, Yvonne Brede, Thomas J Tolbert.   

Abstract

Interleukin-1 receptor antagonist is an inhibitor of the pro-inflammatory action of interleukin-1. The gene encoding for interleukin-1 receptor antagonist (IL-1ra) was cloned into a Pichia pastoris expression vector pPICzalphaA (Invitrogen, USA) and transformed into P. pastoris strain SMD1168H. Multi-copy selection of the gene produced a high expressing strain of IL-1ra that produced 17mg/L of total secreted purified protein. The IL-1ra produced in P. pastoris was a mixture of glycosylated and non-glycosylated IL-1ra where 70% of the total protein was glycosylated. SP-Sepharose purification allowed for separation of the two expressed forms of IL-1ra, which permits biochemical investigation of glycosylated and non-glycosylated IL-1ra using one expression system. Mass spectrometric analysis revealed the expression of the full-length protein and that the glycosylated IL-1ra contained high mannose glycoforms that ranged from Man(9)GlcNAc(2) to Man(14)GlcNAc(2).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18272394     DOI: 10.1016/j.pep.2008.01.003

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  2 in total

1.  Expression of a novel chimeric-truncated tPA in Pichia pastoris with improved biochemical properties.

Authors:  Amirhossein Saadatirad; Soroush Sardari; Mohammadreza Kazemali; Najmeh Zarei; Fatemeh Davami; Farzaneh Barkhordari; Ahmad Adeli; Fereidoun Mahboudi
Journal:  Mol Biotechnol       Date:  2014-12       Impact factor: 2.695

2.  Production, Characterization, and Biological Evaluation of Well-Defined IgG1 Fc Glycoforms as a Model System for Biosimilarity Analysis.

Authors:  Solomon Z Okbazghi; Apurva S More; Derek R White; Shaofeng Duan; Ishan S Shah; Sangeeta B Joshi; C Russell Middaugh; David B Volkin; Thomas J Tolbert
Journal:  J Pharm Sci       Date:  2016-01-09       Impact factor: 3.534

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.